Clinical Trials
11 trialsNCT05043090 2026-05-22
SAMETA
AstraZeneca
Phase 3 Active not recruiting
NCT07227402 2026-05-12
LITESPARK-033
Merck Sharp & Dohme LLC
Phase 3 Recruiting
NCT03091192 2026-04-14
Savolitinib vs. Sunitinib in MET-driven PRCC.
AstraZeneca
Phase 3 Active not recruiting
NCT03937219 2025-09-10
COSMIC-313
Exelixis
Phase 3 Active not recruiting
NCT00606866 2023-11-29
MRI
University of Chicago
Phase 3 Completed
NCT02793128 2020-12-22
Olympus
UroGen Pharma Ltd.
Phase 3 Completed
NCT04225299 2020-11-13
Evaluation of Efficacy of TOOKAD® (VTP) Versus Active Surveillance for Intermediate Risk Localized Prostate Cancer
Steba Biotech S.A.
Phase 3 Withdrawn
NCT04006691 2020-05-07
Retreatment
UroGen Pharma Ltd.
Phase 3 Withdrawn
NCT01310894 2019-07-11
PCM301
Steba Biotech S.A.
Phase 3 Completed
NCT00838201 2018-10-18
Extension Study to Evaluate Long Term Safety of Denosumab in Subjects Undergoing ADT for Non-Metastatic Prostate Cancer
Amgen
Phase 3 Completed
NCT01875393 2016-04-19
PCM304
Steba Biotech S.A.
Phase 3 Completed